These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32892347)

  • 1. Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease.
    Israelian L; Nitschke S; Wang P; Zhao X; Perri AM; Lee JPY; Verhalen B; Nitschke F; Minassian BA
    J Neurochem; 2021 Jun; 157(6):1897-1910. PubMed ID: 32892347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease.
    Duran J; Hervera A; Markussen KH; Varea O; López-Soldado I; Sun RC; Del Río JA; Gentry MS; Guinovart JJ
    Brain; 2021 Sep; 144(8):2349-2360. PubMed ID: 33822008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
    Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
    J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.
    Machado-Salas J; Avila-Costa MR; Guevara P; Guevara J; Durón RM; Bai D; Tanaka M; Yamakawa K; Delgado-Escueta AV
    Exp Neurol; 2012 Jul; 236(1):131-40. PubMed ID: 22542948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.
    Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P
    Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen hyperphosphorylation underlies lafora body formation.
    Turnbull J; Wang P; Girard JM; Ruggieri A; Wang TJ; Draginov AG; Kameka AP; Pencea N; Zhao X; Ackerley CA; Minassian BA
    Ann Neurol; 2010 Dec; 68(6):925-33. PubMed ID: 21077101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PTG variant contributes to a milder phenotype in Lafora disease.
    Guerrero R; Vernia S; Sanz R; Abreu-Rodríguez I; Almaraz C; García-Hoyos M; Michelucci R; Tassinari CA; Riguzzi P; Nobile C; Sanz P; Serratosa JM; Gómez-Garre P
    PLoS One; 2011; 6(6):e21294. PubMed ID: 21738631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex.
    Rubio-Villena C; Garcia-Gimeno MA; Sanz P
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease.
    Valles-Ortega J; Duran J; Garcia-Rocha M; Bosch C; Saez I; Pujadas L; Serafin A; Cañas X; Soriano E; Delgado-García JM; Gruart A; Guinovart JJ
    EMBO Mol Med; 2011 Nov; 3(11):667-81. PubMed ID: 21882344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora.
    Pellegrini P; Hervera A; Varea O; Brewer MK; López-Soldado I; Guitart A; Aguilera M; Prats N; Del Río JA; Guinovart JJ; Duran J
    Mol Neurobiol; 2022 Feb; 59(2):1214-1229. PubMed ID: 34962634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting glycogen synthesis prevents Lafora disease in a mouse model.
    Pederson BA; Turnbull J; Epp JR; Weaver SA; Zhao X; Pencea N; Roach PJ; Frankland PW; Ackerley CA; Minassian BA
    Ann Neurol; 2013 Aug; 74(2):297-300. PubMed ID: 23913475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
    Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
    Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.
    Augé E; Pelegrí C; Manich G; Cabezón I; Guinovart JJ; Duran J; Vilaplana J
    Glia; 2018 Oct; 66(10):2094-2107. PubMed ID: 30152044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen in Astrocytes and Neurons: Physiological and Pathological Aspects.
    Duran J; Gruart A; López-Ramos JC; Delgado-García JM; Guinovart JJ
    Adv Neurobiol; 2019; 23():311-329. PubMed ID: 31667813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.
    Varea O; Duran J; Aguilera M; Prats N; Guinovart JJ
    Neurobiol Dis; 2021 Jan; 147():105173. PubMed ID: 33171226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.